SelectedWorks - Rosa Rodriguez-Monguio

Contact

Selected Works of Rosa Rodriguez-Monguio

Associate Professor, Department of Health Policy and Management, School of Public Health and Health Sciences

Works
About

×

About Rosa Rodriguez-Monguio

Present	Associate Professor, Department of Health Policy and Management, School of Public Health and Health Sciences, University of Massachusetts Amherst
Institution Organization Position Type Position Title Time Period to Options Current Position Affiliate my profile with this Institution
Present	Director of the Health Policy and Management Program, University of Massachusetts Amherst
Institution Organization Position Type Position Title Time Period to Options Current Position Affiliate my profile with this Institution

Cancel

322 Arnold House
University of Massachusetts Amherst
Amherst, MA 01003
Tel:413-545-7427

Healthcare cost of type 1 diabetes mellitus in new-onset children ...

BMC Pediatrics (2013)

Christopher F. Jasinski, Rosa Rodriguez-Monguio, Ksenia Tonyushkina and Holley Allen

Background Type 1 diabetes is among the most prevalent chronic childhood diseases in the US. Initial type 1 diabetes management ...

Changes in FDA Enforcement Activities Following Changes in Federal Administration ...

BMC Health Services Research (2013)

Diane Nguyen, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio and Michael Montagne

Background The United States (US) Food and Drug Administration (FDA) is responsible for the protection of the public health by ...

Comparing the cost of community pharmacy and mail-order pharmacy in ...

International Journal of Health Planning and Management (2012)

J. Visaria, E. Seoane-Vazquez, SL Szeinbach and Rosa Rodriguez-Monguio

Although community pharmacies have been the mainstay for drug distribution in the USA, plan members are encouraged to use mail-order ...

Racial disparities in the risk of developing obesity-related diseases: a ...

Ethnicity and Disease (2012)

H Zhang and Rosa Rodriguez-Monguio

Analyze racial/ethnic disparities in the prevalence of obesity and its related diseases in Massachusetts and assess disparities in the risk ...

Market withdrawal of new molecular entities approved in the United ...

Pharmacoepidemiology and Drug Safety (2011)

ZP. Qureshi, E. Seoane-Vazquez, Rosa Rodriguez-Monguio, KB. Stevenson, et al.

PURPOSE: Economic factors, market dynamics, and safety issues are largely responsible for decisions to withdraw pharmaceutical products from the market. ...

Access to essential drugs in Guyana: a public health challenge

International Journal of Health Planning and Management (2010)

Rosa Rodriguez-Monguio and E. Seoane-Vazquez

Guyana's pharmaceutical sector faces major challenges that limit access to essential drugs. This study analyzes Guyana's drug policy and regulation, ...

Sleep disorders and chronic constipation relation to other co-morbidities

The Open Allergy Journal (2010)

S.L. Szeinbach, Rosa Rodriguez-Monguio, R.W. Baran and P.B. Williams

Sleep disorders are common complaints and frequently associated with a number of disease states. Although the link between sleep disorders, ...

Analysis of the impact of the Uruguay Round Agreements Act ...

Food and Drug Law Journal (2009)

E. Seoane-Vazquez, Rosa Rodriguez-Monguio, SL. Szeinbach, A. Beyer, et al.

The Uruguay Round Agreements Act (URAA) was enacted by the United States Congress in 1994. The URAA provided substantial modifications ...

Patent life of antiretroviral drugs approved in the US from ...

AIDS Care (2009)

Rosa Rodriguez-Monguio

This study analyzes the effective patent life of antiretroviral (ARV) new molecular entities (NMEs) approved for marketing in the United ...

Provision of Health Policy in Canada: Challenges and Opportunities

Electronic Journal of Biomedicine (2009)

Rosa Rodriguez-Monguio, Enrique Seoane-Vazquez and Fernando Antoñanzas Villar

The Canadian health care system provides comprehensive coverage of hospital and outpatient care, including therapeutic, diagnostic and preventive services. The ...

Incentives for orphan drug research and development in the United ...

Orphanet Journal of Rare Diseases (2008)

Rosa Rodriguez-Monguio, Enrique Seoane-Vazquez, Sheryl L. Szeinbach and Jay Visaria

Background The Orphan Drug Act (1983) established several incentives to encourage the development of orphan drugs (ODs) to treat rare ...

Endoscopy-related infection: relic of the past?

Current Opinion in Infectious Diseases (2008)

E. Seoane-Vazquez and Rosa Rodriguez-Monguio

PURPOSE OF REVIEW: Recent outbreaks of nosocomial infection and pseudoinfection have been linked to contaminated endoscopes. This review summarizes the ...

Endoscopy-related infections and toxic reactions: an international comparison

Endoscopy (2007)

E. Seoane-Vazquez, Rosa Rodriguez-Monguio, J. Visaria and A. Carlson

This article is an analysis of the characteristics of exogenous endoscopy-related infections, pseudoinfections, and toxic reactions that have occurred worldwide ...

Drug utilization and cost in a Medicaid population: A simulation ...

BMC Health Services Research (2007)

Rosa Rodriguez-Monguio, Satish Valluri, Enrique Seoane-Vazquez and Sheryl L Szeinbach

Background Outpatient drugs are dispensed through both community and mail order pharmacies. There is no empirical evidence that substitution of ...

Analysis of the World Bank's pharmaceutical lending

Health Policy (2007)

Rosa Rodriguez-Monguio, J. Rovira and E. Seoane-Vázquez

This article analyzes the World Bank's lending activity on pharmaceuticals and medical products (PMP) during the fiscal years (FY) 1999-2001 ...

Negotiating antiretroviral drug prices: the experience of the Andean countries

Health Policy Plan (2007)

E. Seoane-Vazquez and Rosa Rodriguez-Monguio

This study analyses the effect of the Andean countries' June 2003 negotiation of antiretroviral drug (ARV) prices. The objectives were ...

Exogenous endoscopy-related infections, pseudo-infections, and toxic reactions: clinical and economic ...

Current Medical Research & Opinion (2006)

E. Seoane-Vazquez, Rosa Rodriguez-Monguio, J. Visaria and A. Carlson

OBJECTIVES: The objective of this study was to analyze the characteristics and costs of exogenous endoscopy-related infections, pseudo-infections, and toxic ...

Healthcare rationing in Spain: framework, descriptive analysis and consequences

Pharmacoeconomics (2006)

Rosa Rodriguez-Monguio and Villar F Antoñanzas

This paper describes the main healthcare rationing policies implemented in Spain over the last 2 decades, and analyses the consequences ...

Assessing the economic impact of adverse drug effects

Pharmacoeconomics (2003)

Rosa Rodriguez-Monguio, MJ. Otero and J. Rovira

Although most commonly used drugs cause adverse effects, some of them with potentially serious consequences, relatively little is known about ...